Skip to main content
. 2010 Mar 17;298(6):F1504–F1514. doi: 10.1152/ajprenal.00025.2010

Fig. 5.

Fig. 5.

Reduced EPC and stem cell recruitment to the kidney, but enhanced EPC stimulation due to EPO therapy. Circulating levels of EPC (A) and HSC (B) as well as splenic EPC (C) and HSC (D) were measured using FACS analysis. EPO significantly reduced renal EPC recruitment (E), and HSC were unchanged (F). No differences occurred for EPC (G) and HSC (H) of the right kidneys. *P < 0.05, **P < 0.01, and ***P < 0.001 by Mann-Whitney test.